SARGENT INVESTMENT GROUP, LLC – Eli Lilly and Company Transaction History
SARGENT INVESTMENT GROUP, LLC portfolio value:
$701,000
portfolio value
SARGENT INVESTMENT GROUP, LLC quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -5.18% | -115 shares | -18K | $323.35 | 2.10K |
| Q2 2022 | share | Decrease | -5.53% | -130 shares | 46K | $324.23 | 2.21K |
| Q1 2022 | share | 0.00% | 0 shares | 24K | $286.37 | 2.34K | |
| Q4 2021 | share | Decrease | -3.29% | -80 shares | 88K | $277.25 | 2.34K |
| Q3 2021 | share | 0.00% | 0 shares | 3K | $230.3 | 2.42K | |
| Q2 2021 | share | Decrease | -0.82% | -20 shares | 100K | $228.04 | 2.42K |
| Q1 2021 | share | Increase | +6.52% | 150 shares | 70K | $184.81 | 2.44K |
| Q4 2020 | share | 0.00% | 0 shares | 48K | $166.32 | 2.29K | |
| Q3 2020 | share | Increase | +9.53% | 200 shares | -3K | $145.05 | 2.29K |
| Q2 2020 | share | Increase | +30.05% | 485 shares | 119K | $160.1 | 2.09K |
| Q1 2020 | share | Increase | 0.00% | 1.61K shares | 224K | $134.64 | 1.61K |